Deutsche Bank’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-132,597
| Closed | -$137K | – | 5740 |
|
|
2019
Q1 | $137K | Buy |
132,597
+77,897
| +142% | +$63.4K | ﹤0.01% | 4192 |
|
|
2018
Q4 | $40K | Buy |
+54,700
| New | +$82.3K | ﹤0.01% | 4560 |
|
|
2018
Q2 | – | Sell |
-54
| Closed | – | – | 5807 |
|
|
2018
Q1 | $0 | Sell |
54
-2,930
| -98% | -$8.07K | ﹤0.01% | 5851 |
|
|
2017
Q4 | $12K | Buy |
2,984
+1,568
| +111% | +$6.82K | ﹤0.01% | 4758 |
|
|
2017
Q3 | $5K | Sell |
1,416
-17,980
| -93% | -$72.8K | ﹤0.01% | 4750 |
|
|
2017
Q2 | $63K | Sell |
19,396
-98,489
| -84% | -$409K | ﹤0.01% | 4325 |
|
|
2017
Q1 | $1.08M | Sell |
117,885
-9,224
| -7% | -$81K | ﹤0.01% | 2601 |
|
|
2016
Q4 | $979K | Buy |
127,109
+36,075
| +40% | +$331K | ﹤0.01% | 2714 |
|
|
2016
Q3 | $1.04M | Buy |
91,034
+46,674
| +105% | +$543K | ﹤0.01% | 2804 |
|
|
2016
Q2 | $544K | Buy |
44,360
+4,116
| +10% | +$49.9K | ﹤0.01% | 3235 |
|
|
2016
Q1 | $406K | Buy |
40,244
+10,089
| +33% | +$118K | ﹤0.01% | 3336 |
|
|
2015
Q4 | $678K | Sell |
30,155
-28,320
| -48% | -$580K | ﹤0.01% | 3120 |
|
|
2015
Q3 | $969K | Buy |
58,475
+6,233
| +12% | +$125K | ﹤0.01% | 2974 |
|
|
2015
Q2 | $1.17M | Buy |
52,242
+9,486
| +22% | +$234K | ﹤0.01% | 2861 |
|
|
2015
Q1 | $1.1M | Sell |
42,756
-55,195
| -56% | -$1.4M | ﹤0.01% | 2830 |
|
|
2014
Q4 | $2.13M | Sell |
97,951
-2,938
| -3% | -$60.2K | ﹤0.01% | 2625 |
|
|
2014
Q3 | $1.91M | Buy |
100,889
+19,776
| +24% | +$397K | ﹤0.01% | 2552 |
|
|
2014
Q2 | $1.89M | Buy |
81,113
+13,340
| +20% | +$329K | ﹤0.01% | 2484 |
|
|
2014
Q1 | $2.28M | Sell |
67,773
-49,566
| -42% | -$1.67M | ﹤0.01% | 2328 |
|
|
2013
Q4 | $3.46M | Buy |
117,339
+700
| +0.6% | +$12.8K | ﹤0.01% | 1979 |
|
|
2013
Q3 | $1.78M | Buy |
+116,639
| New | +$2.16M | ﹤0.01% | 2560 |
|
Deutsche Bank's OMED Position: Q2 2019 in Review
Deutsche Bank sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 132,597 shares — an estimated $137K sold.
Deutsche Bank first reported a position in OMED in Q3 2013 and held it in 21 quarters. The position peaked at $3.46M in Q4 2013. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Deutsche Bank reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Deutsche Bank sold 132,597 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $137K.
- Deutsche Bank first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 21 quarters.
- Deutsche Bank's OncoMed Pharmaceuticals, Inc. position peaked at $3.46M in Q4 2013.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.